We are live on ! Find out more
EAM

Exos Asset Management Portfolio holdings

AUM $2.32K
1-Year Est. Return 108.13%
This Fund
S&P 500
This Quarter Est. Return
+1.15%
1 Year Est. Return
+108.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.3M
AUM Growth
-$81.8M
Cap. Flow
-$81.1M
Cap. Flow %
-92.91%
Top 10 Hldgs %
37.21%
Holding
193
New
9
Increased
5
Reduced
23
Closed
48
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGAAW
101
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$6.11K 0.01%
55,500
FLDDW
102
Fold Holdings Warrant
FLDDW
$995K
$6K 0.01%
150,000
NETDW
103
DELISTED
Nabors Energy Transition Corp II Warrant
NETDW
$5.87K 0.01%
58,728
INTEW
104
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$5.76K 0.01%
57,624
MITAW
105
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.45K 0.01%
108,935
AVHIW
106
DELISTED
Achari Ventures Holdings Corp I Warrant
AVHIW
$5.41K 0.01%
186,400
NVNIW
107
Nvni Group Limited Warrants
NVNIW
$5.32K 0.01%
304,409
XFINW
108
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
$5.3K 0.01%
176,180
MRNOW
109
Murano Global Investments PLC Warrants
MRNOW
$5.1K 0.01%
30,923
NBSTW
110
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$4.98K 0.01%
81,224
OAKU
111
DELISTED
Oak Woods Acquisition Corp
OAKU
$4.9K 0.01%
450
-174,059
-100% -$1.88M
MARXR
112
DELISTED
Mars Acquisition Corp. Rights
MARXR
$4.75K 0.01%
24,997
OIOWW
113
OIO Group Warrants
OIOWW
$4.72K 0.01%
362,935
CLDI.WS
114
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$4.42K 0.01%
105,000
LSBPW
115
DELISTED
LakeShore Biopharma Warrants
LSBPW
$4.4K 0.01%
50,000
PUCKW
116
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$4.28K ﹤0.01%
535,113
AERTW
117
Aeries Technology Warrant
AERTW
$4.19K ﹤0.01%
144,634
ASBPW
118
Aspire Biopharma Warrant
ASBPW
$447K
$4.11K ﹤0.01%
137,000
OSRHW
119
OSR Health Warrant
OSRHW
$4K ﹤0.01%
200,000
AITRR
120
DELISTED
AI Transportation Acquisition Corp Right
AITRR
$3.8K ﹤0.01%
20,000
ATEK.WS
121
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$3.78K ﹤0.01%
107,700
BNZIW icon
122
Banzai International Warrant
BNZIW
$144K
$3.5K ﹤0.01%
225,579
ZLSWW
123
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$3.29K ﹤0.01%
82,133
HCVIW
124
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$3.21K ﹤0.01%
21,425
HSPOW
125
DELISTED
Horizon Space Acquisition I Corp Warrant
HSPOW
$3.08K ﹤0.01%
177,938

Similar funds

Exos Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Exos Asset Management held 193 positions worth $87.3M, down 48% from $169M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Exos Asset Management withdrew a net $81.1M in Q2 2024, closing 48 positions and reducing 23 holdings. Its most notable exit was Compass Digital Acquisition Corp. Class A Ordinary Shares, an estimated $3.65M position sold in full.

By sector, the portfolio is most concentrated in Financials at 82% of assets, up from 77% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exos Asset Management opened a new position in IB Acquisition Corp worth $3.19M.

  • Exos Asset Management's largest Q2 2024 buy was IB Acquisition Corp: 320,000 shares worth $3.19M.
  • Exos Asset Management added most to Alchemy Investments Acquisition Corp 1 in Q2 2024, an estimated $1.18M increase.
  • Exos Asset Management's biggest Q2 2024 reduction was Israel Acquisitions Corp, cutting an estimated $2.74M.
  • Exos Asset Management fully exited Compass Digital Acquisition Corp. Class A Ordinary Shares in Q2 2024, selling an estimated $3.65M.
  • Exos Asset Management's ten largest holdings make up 37% of its $87.3M portfolio in Q2 2024.
  • Exos Asset Management opened 9 new positions and closed 48 in Q2 2024.
  • Exos Asset Management's portfolio value fell 48% quarter-over-quarter to $87.3M.

Based on Exos Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.